US equities
|
MU
$970.32
▲+4.47%
META
$611.78
▼-1.36%
TSLA
$402.78
▼-1.15%
SPCX
$144.15
▼-2.98%
NVDA
$217.12
▼-0.38%
SNDK
$1,379.06
▲+5.69%
GOOGL
$324.13
▲+1.11%
SKHY
$164.41
▲+13.10%
MU
$970.32
▲+4.47%
META
$611.78
▼-1.36%
TSLA
$402.78
▼-1.15%
SPCX
$144.15
▼-2.98%
NVDA
$217.12
▼-0.38%
SNDK
$1,379.06
▲+5.69%
GOOGL
$324.13
▲+1.11%
SKHY
$164.41
▲+13.10%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Cybin IRL Limited
Recent news which mentions Cybin IRL Limited
Cybin Moves Forward With Phase 1/2a Clinical Trial For Treatment Of Major Depressive Disorder
June 10, 2022
Tickers
CYBN
Tags
CYBN
News
FDA
From
Benzinga